Trastuzumab emtansine (T-DM1) in previously treated HER2-positive metastatic breast cancer (MBC): Results from an expanded access study.
Denise Aysel Yardley
Consultant or Advisory Role - Genentech (U)
Ian E. Krop
Consultant or Advisory Role - Genentech/Roche (U)
Research Funding - Genentech
Patricia LoRusso
Consultant or Advisory Role - Genentech
Research Funding - Genentech
Nicholas J. Robert
Honoraria - Roche
Research Funding - Genentech/Roche
Musa Mayer
No relevant relationships to disclose
Oyewale O. Abidoye
Employment or Leadership Position - Genentech
Stock Ownership - Roche/Genentech
Catherine Lai
Employment or Leadership Position - Genentech
Stock Ownership - Genentech
Bongin Yoo
Employment or Leadership Position - Genentech
Stock Ownership - Genentech
Edith A. Perez
No relevant relationships to disclose